Global Biobanking Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2020 growth of Biobanking will have significant change from previous year. By the most conservative estimates of global Biobanking market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2676.4 million in 2019. Over the next five years the Biobanking market will register a 6.0% CAGR in terms of revenue, the global market size will reach US$ 3381 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Biobanking market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Equipment
Consumable

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Virtual Biobanks
Tissue Biobanks
Population Biobanks

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Beckman Coulter
Thermo Fisher
Panasonic
Sigma-Aldrich
SOL Group
Promega
BD
Brooks Life Science
QIAGEN
Tecan Group
Lifeline Scientific
So-Low
LVL Technologies
DNA Genotek
Micronic
Askion
Biolife Solutions
Cryo Bio System
BioRep

Frequently Asked Questions